Page 3 of 5

Re: Pharmaceutical R&D on neuropathic pain

Posted: Wed May 16, 2012 1:33 am
by Dave
jogom wrote:By the way, i found that very interesating page
http://www.nature.com/nrd/journal/v11/n ... nrd3624_T1.
Thanks. A good find at that link is Ralfinamide, a drug in phase 2.  The maker is Newron Pharmaceuticals, an Italian company. They claim that Ralfinamide is an inhibitor of sodium channels, calcium channels, and NMDA receptors.

Re: Pharmaceutical R&D on neuropathic pain

Posted: Wed May 16, 2012 1:52 pm
by jogom
and finally
http://www.biocetera.com/inthenews.php?id=148537
I hope it can be on the market soon.

Re: Pharmaceutical R&D on neuropathic pain

Posted: Sat May 19, 2012 3:38 pm
by jogom
Does anybody hear aboute XEN402?

Re: Pharmaceutical R&D on neuropathic pain

Posted: Mon May 21, 2012 7:47 pm
by Dave
jogom wrote:Does anybody hear aboute XEN402?
This drug is interesting because Xenon looks for cures by studying the "opposite phenotype."   For example, they have been looking for chronic pain cures by studying the genes of people who congenitally cannot feel pain.  It is one of the few  companies really looking at pain from a DNA level.

This drug XEN402 is targeted to a very specific sodium channel in the nerve associated with pain.  Let's HOPE it is successful... 

Re: Pharmaceutical R&D on neuropathic pain

Posted: Thu May 24, 2012 11:11 am
by jogom
I gess you mean the SCN9A of a pakistani family. I see you know a lot of companies that are involved on research.

Re: Pharmaceutical R&D on neuropathic pain

Posted: Fri Jun 08, 2012 5:18 pm
by Dave
Nektar Therapeutics (CA) is another company doing some interesting work. Their main focus seems to be using their polymer drug delivery technology to reduce the adverse effects of opioids:

scroll down to the "pain" section:
http://www.nektar.com/product_pipeline/ ... l#NKTR-171

http://www.marketwatch.com/story/nektar ... 2012-06-07

Re: Pharmaceutical R&D on neuropathic pain

Posted: Mon Jun 11, 2012 10:22 pm
by Dave
See also news on Sativex (GW Pharma). This product is a marijuana extract in a spray form. The first application is cancer pain, but it will also be trialed for neuropathic pain.

http://americannewsreport.com/marijuana ... 14518.html

http://www.gwpharm.com/sativex.aspx

http://www.gwpharm.com/Third%20phase%20 ... ences.aspx

Re: Pharmaceutical R&D on neuropathic pain

Posted: Sat Jun 23, 2012 11:21 pm
by Dave
This is a very long way from being commercially available, but if there is any to this gene therapy for neuropathic pain, it would be a phenomenal breakthrough. If our great grandchildren can simply go to the doctor and be cured of this....

http://www.diamyd.com/docs/ntddsPlatfor ... on=science

Re: Pharmaceutical R&D on neuropathic pain

Posted: Wed Sep 26, 2012 1:39 pm
by Dave
Btw, here is another company in Virginia and another in Spain.

http://www.xdynia.com
http://www.esteve.es/EsteveFront/Cargar ... idi&lng=en

Re: Pharmaceutical R&D on neuropathic pain

Posted: Sat Oct 06, 2012 10:10 am
by helenlegs 11
deadly-black-mamba-venom-could-kill-pain

http://news.sky.com/story/992914/deadly ... -kill-pain